The HKAPI submits this Policy Address Recommendation on behalf of its 33 member companies engaging in the research and development of novel pharmaceuticals. Our member companies provide over 70 per cent of the prescription medicines in Hong Kong. 

The Association has actively participated in the events of the local health community and regularly presented its views to the public on different healthcare issues. View more here